Flexion Therapeutics to Present at Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference

By GlobeNewswire,  June 11, 2014, 09:13:00 AM EDT


BURLINGTON, Mass., June 11, 2014 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that CEO Michael Clayman, M.D., will present at the Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference at 3:00 p.m. Eastern Time on Wednesday, June 18, 2014 at the Intercontinental Hotel in Boston.

To access the live webcast and subsequent archived recordings for the presentation, please visit the Flexion website at http://flexiontherapeutics.com/.

About Flexion Therapeutics

Flexion is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel pain therapies. The company is currently advancing a portfolio of injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapy. The company's lead program, FX006, is an intra-articular sustained release steroid in development for patients with moderate to severe OA pain. The company also has two additional product candidates, FX007, a locally administered TrkA receptor antagonist for post-operative pain, and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor for end-stage OA patients.

CONTACT: Media Contact
         Jamie Lacey-MoreiraPressComm PR, LLC
         T: 410-299-3310
         jamielacey@presscommpr.com

         Corporate Contact
         Lisa Davidson, MBA
         Vice President, Finance and Administration
         Flexion Therapeutics, Inc.
         T: 781-305-7765
         ldavidson@flexiontherapeutics.com
Source: Flexion Therapeutics, Inc.

This article appears in: News Headlines

Referenced Stocks: FLXN


Latest News Video





Most Active by Volume

Company Last Sale Change Net / %
AMD $ 3.91 0.09 ▲ 2.36%
S $ 7.37 0.39 ▼ 5.03%
BAC $ 15.25 0.33 ▼ 2.12%
MU $ 30.55 1.98 ▼ 6.09%
SYF $ 23 unch
AAPL $ 95.60 2.55 ▼ 2.60%
QQQ $ 95.02 1.96 ▼ 2.02%
TWTR $ 45.19 1.11 ▼ 2.40%

As of 7/31/2014, 04:07 PM